{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:34:51Z","timestamp":1791689691601,"version":"4.3.4"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,2,15]]},"DOI":"10.2169\/internalmedicine.5829-25","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T22:10:19Z","timestamp":1753308619000},"page":"615-620","source":"Crossref","is-referenced-by-count":3,"title":["Disseminated Strongyloidiasis Following Chemoradiotherapy for Lung Cancer in a Patient Living in a Non-endemic Area in Japan"],"prefix":"10.2169","volume":"65","author":[{"given":"Nobumasa","family":"Okumura","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Anjo Kosei Hospital, Japan"},{"name":"Department of Infectious Diseases, Nagoya City University East Medical Center, Japan"},{"name":"Department of Infectious Diseases, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Torii","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Anjo Kosei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Anjo Kosei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Anjo Kosei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahori","family":"Iwade","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Anjo Kosei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Anjo Kosei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. World Health Organization [Internet]. [cited 2025 Jan 16]. Available from: https:\/\/www.who.int\/health-topics\/neglected-tropical-diseases#tab=tab_1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ikuno H, Ishikawa T, Norose K. Status of strongyloidiasis in Japan, 2000-2017. Am J Trop Med Hyg 103: 727-734, 2020.","DOI":"10.4269\/ajtmh.19-0969"},{"key":"3","unstructured":"3. Yoshikawa M, Ouji Y, Nakamura-Uchiyama F, Nawa Y. Analysis of strongyloidiasis cases reported in Japan in the recent period, 2000-2013. Clin Parasitol 25: 20-26, 2014 (in Japanese)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hirata T, Nakamura H, Kinjo N, et al. Prevalence of <i>Blastocystis hominis<\/i> and <i>Strongyloides stercoralis<\/i> infection in Okinawa, Japan. Parasitol Res 101: 1717-1719, 2007.","DOI":"10.1007\/s00436-007-0712-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mukaigawara M, Narita M, Shiiki S, Takayama Y, Takakura S, Kishaba T. Clinical characteristics of disseminated strongyloidiasis, Japan, 1975-2017. Emerg Infect Dis 26: 401-408, 2020.","DOI":"10.3201\/eid2603.190571"},{"key":"6","unstructured":"6. Research Group of Tropical Diseases and Parasitic Diseases. Treatment manual for parasitic diseases, 2020. version 10.2 [Internet]. [cited 2023 Oct 19]. Available from: https:\/\/www.nettai.org\/app\/download\/11802366291\/%E5%AF%84%E7%94%9F%E8%99%AB%E7%97%87%E8%96%AC%E7%89%A9%E6%B2%BB%E7%99%82%E3%81%AE%E6%89%8B%E5%BC%95%E3%81%8D2020%2810.2%29.pdf?t=1664928593"},{"key":"7","unstructured":"7. CDC. Available from: https:\/\/www.cdc.gov\/dpdx\/strongyloidiasis\/index.html"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Pivoto Jo\u00e3o GA, Alves Antunes IF, Mendes Dos Santos L. Fatal disseminated strongyloidiasis with periumbilical purpura. Am J Trop Med Hyg 105: 860-861, 2021.","DOI":"10.4269\/ajtmh.21-0464"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nabeya D, Haranaga S, Parrott GL, et al. Pulmonary strongyloidiasis: assessment between manifestation and radiological findings in 16 severe strongyloidiasis cases. BMC Infect Dis 17: 320, 2017.","DOI":"10.1186\/s12879-017-2430-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Woodring JH, Halfhill H 2nd, Berger R, Reed JC, Moser N. Clinical and imaging features of pulmonary strongyloidiasis. South Med J 89: 10-19, 1996.","DOI":"10.1097\/00007611-199601000-00002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mejia R, Nutman TB. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by <i>Strongyloides stercoralis<\/i>. Curr Opin Infect Dis 25: 458-463, 2012.","DOI":"10.1097\/QCO.0b013e3283551dbd"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kim JM, Sivasubramanian G. Strongyloides hyperinfection syndrome among COVID-19 patients treated with corticosteroids. Emerg Infect Dis 28: 1531-1533, 2022.","DOI":"10.3201\/eid2807.220198"},{"key":"13","unstructured":"13. CDC. Available from: https:\/\/www.cdc.gov\/strongyloides\/hcp\/clinical-care\/index.html"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shikiya K, Zaha O, Niimura S, et al. Clinical study on ivermectin against 125 Strongylodiasis patients. Kansenshogaku Zasshi (J Jpn Assoc Infect Dis) 68: 13-20, 1994 (in Japanese).","DOI":"10.11150\/kansenshogakuzasshi1970.68.13"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zaha O, Hirata T, Uchima N, Kinjo F, Saito A. Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody. J Infect Chemother 10: 348-351, 2004.","DOI":"10.1007\/s10156-004-0345-Z"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Satoh M, Toma H, Sato Y, et al. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1. Clin Exp Immunol 127: 354-359, 2002.","DOI":"10.1046\/j.1365-2249.2002.01733.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. DeVault GA Jr, King JW, Rohr MS, Landreneau MD, Brown ST 3rd, McDonald JC. Opportunistic infections with <i>Strongyloides stercoralis<\/i> in renal transplantation. Rev Infect Dis 12: 653-671, 1990.","DOI":"10.1093\/clinids\/12.4.653"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Boggild AK, Libman M, Greenaway C, McCarthy AE; Committee to Advise on Tropical Medicine, Travel (CATMAT). CATMAT statement on disseminated strongyloidiasis: prevention, assessment and management guidelines. Can Commun Dis Rep 42: 12-19, 2016.","DOI":"10.14745\/ccdr.v42i01a03"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Krolewiecki A, Nutman TB. Strongyloidiasis: a neglected tropical disease. Infect Dis Clin North Am 33: 135-151, 2019.","DOI":"10.1016\/j.idc.2018.10.006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Stauffer WM, Alpern JD, Walker PF. COVID-19 and dexamethasone: a potential strategy to avoid steroid-related <i>Strongyloides<\/i> hyperinfection. JAMA 324: 623-624, 2020.","DOI":"10.1001\/jama.2020.13170"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/4\/65_5829-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:43:05Z","timestamp":1771645385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/4\/65_5829-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5829-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]},"article-number":"5829-25"}}